✦ LIBER ✦

To statin or to non-statin in coronary disease—considering absolute risk is the answer

✍ Scribed by Christopher M. Rembold

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

To statin or to non-statin in coronary d

✍ Christopher M. Rembold 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 121 KB

P267 NON HIGH-DENSITY LIPOPROTEIN CHOLES

✍ Mizuno, K.; Nakamura, H. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

482 C-REACTIVE PROTEIN (CRP) AND LIPID L

✍ Arsenault, B.J.; Boekholdt, S.M.; Deedwania, P.; DeMicco, D.A.; Bao, W.H.; Prest 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Switching from Statin Monotherapy to EZE

✍ Philippe Brudi; Helena Vaverkova; Michael Farnier; Qian Dong; Amy O. Johnson-Lev 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 45 KB

COST-EFFECTIVE PRIMARY PREVENTION OF COR

✍ Galper, Benjamin Z.; Moran, Andrew; Pletcher, Mark J.; Coxson, Pamela; Lazar, La 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Should we measure C-reactive protein lev

✍ Abhinav Goyal; Michael Blazing 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 62 KB